−0.0085 EUR
−684.40 K EUR
2.18 M EUR
46.82 M
About LEVEL BIO
Sector
Industry
CEO
Joakim Grånemo
Website
Headquarters
Nacka
Founded
1998
ISIN
SE0000885501
FIGI
BBG010S1SPG2
Level Bio AB engages in the development, manufacturing, and marketing of instruments for deoxyribonucleic acid analysis. Its products include Clinical diagnostics, Extraction and purification, Biobank, General lab equipment, Next-generation sequencing, PCR, Cloning and Single-cell. The Company was founded in 1998 and is headquartered in Nacka, Sweden.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange LEVEL BIO AB SK1 stocks are traded under the ticker 4MB.
Yes, you can track LEVEL BIO AB SK1 financials in yearly and quarterly reports right on TradingView.
4MB net income for the last quarter is −76.66 K EUR, while the quarter before that showed −118.76 K EUR of net income which accounts for 35.45% change. Track more LEVEL BIO AB SK1 financial stats to get the full picture.
No, 4MB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 28, 2025, the company has 11 employees. See our rating of the largest employees — is LEVEL BIO AB SK1 on this list?
Like other stocks, 4MB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEVEL BIO AB SK1 stock right from TradingView charts — choose your broker and connect to your account.